Raia Drogasil S.A. (RADLY)
USD 3.37
(-4.8%)
USD 3.37
(-4.8%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 33.97 Billion BRL | 16.88% |
| 2022 | 29.06 Billion BRL | 20.48% |
| 2021 | 24.12 Billion BRL | 20.23% |
| 2020 | 20.06 Billion BRL | 14.24% |
| 2019 | 17.56 Billion BRL | 18.67% |
| 2018 | 14.8 Billion BRL | 12.03% |
| 2017 | 13.21 Billion BRL | 17.38% |
| 2016 | 11.25 Billion BRL | 26.51% |
| 2015 | 8.89 Billion BRL | 20.38% |
| 2014 | 7.39 Billion BRL | 18.59% |
| 2013 | 6.23 Billion BRL | 15.84% |
| 2012 | 5.38 Billion BRL | 97.14% |
| 2011 | 2.72 Billion BRL | 36.11% |
| 2010 | 2 Billion BRL | 16.55% |
| 2009 | 1.72 Billion BRL | 36.54% |
| 2008 | 1.26 Billion BRL | 51.27% |
| 2007 | 833.06 Million BRL | 23.52% |
| 2006 | 674.42 Million BRL | 25.09% |
| 2005 | 539.16 Million BRL | 26.29% |
| 2004 | 426.91 Million BRL | 23.86% |
| 2003 | 344.67 Million BRL | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.1 Billion BRL | 1.97% |
| 2024 Q2 | 9.68 Billion BRL | 6.45% |
| 2023 Q4 | 8.92 Billion BRL | 2.86% |
| 2023 Q3 | 8.67 Billion BRL | 2.77% |
| 2023 Q1 | 7.93 Billion BRL | 1.21% |
| 2023 Q2 | 8.44 Billion BRL | 6.44% |
| 2023 FY | 33.97 Billion BRL | 16.88% |
| 2022 Q4 | 7.83 Billion BRL | 4.62% |
| 2022 Q1 | 6.56 Billion BRL | 1.37% |
| 2022 Q2 | 7.17 Billion BRL | 9.39% |
| 2022 FY | 29.06 Billion BRL | 20.48% |
| 2022 Q3 | 7.48 Billion BRL | 4.33% |
| 2021 Q3 | 6.16 Billion BRL | 5.05% |
| 2021 FY | 24.12 Billion BRL | 20.23% |
| 2021 Q4 | 6.47 Billion BRL | 5.01% |
| 2021 Q1 | 5.62 Billion BRL | 1.19% |
| 2021 Q2 | 5.86 Billion BRL | 4.42% |
| 2020 Q1 | 4.94 Billion BRL | 3.44% |
| 2020 Q2 | 4.46 Billion BRL | -9.7% |
| 2020 Q4 | 5.55 Billion BRL | 9.04% |
| 2020 FY | 20.06 Billion BRL | 14.24% |
| 2020 Q3 | 5.09 Billion BRL | 13.95% |
| 2019 Q3 | 4.6 Billion BRL | 8.9% |
| 2019 FY | 17.56 Billion BRL | 18.67% |
| 2019 Q1 | 3.95 Billion BRL | -1.09% |
| 2019 Q2 | 4.22 Billion BRL | 6.88% |
| 2019 Q4 | 4.78 Billion BRL | 3.99% |
| 2018 Q1 | 6.86 Billion BRL | 96.13% |
| 2018 FY | 14.8 Billion BRL | 12.03% |
| 2018 Q4 | 3.99 Billion BRL | -46.8% |
| 2018 Q3 | 7.51 Billion BRL | 107.9% |
| 2018 Q2 | 3.61 Billion BRL | -47.37% |
| 2017 Q1 | 3.05 Billion BRL | 0.0% |
| 2017 Q4 | 3.5 Billion BRL | 2.47% |
| 2017 FY | 13.21 Billion BRL | 17.38% |
| 2017 Q3 | 3.41 Billion BRL | 5.55% |
| 2017 Q2 | 3.23 Billion BRL | 5.89% |
| 2016 Q4 | 3.05 Billion BRL | 5.38% |
| 2016 FY | 11.25 Billion BRL | 26.51% |
| 2016 Q1 | 2.51 Billion BRL | 2.33% |
| 2016 Q3 | 2.9 Billion BRL | 4.23% |
| 2016 Q2 | 2.78 Billion BRL | 10.65% |
| 2015 FY | 8.89 Billion BRL | 20.38% |
| 2015 Q2 | 2.18 Billion BRL | 11.15% |
| 2015 Q4 | 2.45 Billion BRL | 7.57% |
| 2015 Q3 | 2.28 Billion BRL | 4.5% |
| 2015 Q1 | 1.96 Billion BRL | -2.58% |
| 2014 FY | 7.39 Billion BRL | 18.59% |
| 2014 Q1 | 1.65 Billion BRL | -1.27% |
| 2014 Q2 | 1.79 Billion BRL | 7.97% |
| 2014 Q3 | 1.92 Billion BRL | 7.34% |
| 2014 Q4 | 2.01 Billion BRL | 5.07% |
| 2013 Q4 | 1.67 Billion BRL | 3.35% |
| 2013 FY | 6.23 Billion BRL | 15.84% |
| 2013 Q3 | 1.62 Billion BRL | 5.63% |
| 2013 Q2 | 1.53 Billion BRL | 10.84% |
| 2013 Q1 | 1.38 Billion BRL | -2.5% |
| 2012 Q1 | 1.23 Billion BRL | 18.77% |
| 2012 FY | 5.38 Billion BRL | 97.14% |
| 2012 Q4 | 1.42 Billion BRL | 1.99% |
| 2012 Q3 | 1.39 Billion BRL | 5.5% |
| 2012 Q2 | 1.32 Billion BRL | 6.98% |
| 2011 FY | 2.72 Billion BRL | 36.11% |
| 2011 Q3 | 599.84 Million BRL | 5.85% |
| 2011 Q2 | 566.7 Million BRL | 8.72% |
| 2011 Q1 | 521.27 Million BRL | -2.79% |
| 2011 Q4 | 1.04 Billion BRL | 73.64% |
| 2010 Q1 | 461.37 Million BRL | -2.74% |
| 2010 FY | 2 Billion BRL | 16.55% |
| 2010 Q4 | 536.2 Million BRL | 4.18% |
| 2010 Q3 | 514.69 Million BRL | 4.41% |
| 2010 Q2 | 492.94 Million BRL | 6.84% |
| 2009 FY | 1.72 Billion BRL | 36.54% |
| 2009 Q4 | 474.37 Million BRL | 4.03% |
| 2009 Q3 | 456.01 Million BRL | 7.24% |
| 2009 Q2 | 425.22 Million BRL | 16.52% |
| 2009 Q1 | 364.93 Million BRL | 0.0% |
| 2008 FY | 1.26 Billion BRL | 51.27% |
| 2007 FY | 833.06 Million BRL | 23.52% |
| 2006 FY | 674.42 Million BRL | 25.09% |
| 2005 FY | 539.16 Million BRL | 26.29% |
| 2004 FY | 426.91 Million BRL | 23.86% |
| 2003 FY | 344.67 Million BRL | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -17301.155% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -76251252.261% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | -167396.067% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -25772.177% |
| MedGen, Inc. | 1.05 USD | -3235599047519.048% |
| Omni Health, Inc. | 4.69 Million USD | -723471.399% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | -55542578.242% |
| Pineapple, Inc. | 381.89 Thousand USD | -8896124.044% |
| ScripsAmerica, Inc. | 30.85 Million USD | -110009.119% |